. . . "clinical trial"@en . . "klinisch onderzoek"@nl . . . . . . . . . . . . . . "NCT01142388" . . . . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . "2010-09-21T00:00:00Z"^^ . . "Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer"@en . . . . "94"^^ . . . "18"^^ . . . . . . . . . . . . . . . . "Randomized Phase II Study of Paclitaxel With or Without the Anti-IGF-IR mAb Cixutumumab (IMC-A12) as Second Line Treatment for Patients With Metastatic Esophageal or GE Junction Cancer"@en . . . . . . "Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer"@en . . "Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer"@en . . . . . . . "2014-07-15T00:00:00Z"^^ . "ensayu cl\u00EDnicu"@ast . . . . . .